Clinical Trial Update: Early Detection of Prostate Cancer by FACS

View source ↗

Summary

A clinical trial update on using fluorescence-activated cell sorting (FACS) for early detection of prostate cancer; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Snippet

Sponsor: Ziv Hospital | Conditions: Prostate Cancer, Hyperplasia | Status: UNKNOWN